Literature DB >> 8541034

The somatostatin-gastrin link of Helicobacter pylori infection.

J Calam1.   

Abstract

Helicobacter pylori is the new-found cause of duodenal ulcers (DU), but acid secretion remains necessary and is elevated in DU patients. My group and others have asked whether H. pylori itself alters gastric physiology. This infection has been found to decrease local expression of the inhibitory peptide somatostatin, and to increase release of the acid-stimulating hormone gastrin. H. pylori infection can alter acid secretion in both directions. Acid disappears temporarily on first infection, and may dwindle later if H. pylori causes gastric atrophy. DU patients have approximately twice the normal parietal cell mass, which increases their maximal secretory capacity, but it is not clear whether or not this is due to H. pylori. However, the infection certainly does change physiological control of acid secretion, as expected from the endocrine changes. Acid secretion is elevated during fasting, during stimulation with an acidic meal and during infusions of gastrin-releasing peptide. The balance between these opposing effects of H. pylori on acid may be crucial in determining the clinical outcome of H. pylori infection. High-acid secretion leads to DUs whilst low acid secretion is found in patients with gastric ulcers and gastric cancer. Inflammatory cytokines released in H. pylori gastritis may cause some of these changes in gastric physiology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8541034     DOI: 10.3109/07853899509002471

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  10 in total

1.  Helicobacter pylori infection and gastrointestinal hormones:a review.

Authors:  Xiang-Qian Huang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Suppressed Gastric Mucosal TGF-beta1 Increases Susceptibility to H. pylori-Induced Gastric Inflammation and Ulceration: A Stupid Host Defense Response.

Authors:  Yunjeong Jo; Sang Uk Han; Yoon Jae Kim; Ju Hyeon Kim; Shin Tae Kim; Seong-Jin Kim; Ki-Baik Hahm
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

3.  The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas.

Authors:  Gwen Murphy; Farin Kamangar; Sanford M Dawsey; Frank Z Stanczyk; Stephanie J Weinstein; Philip R Taylor; Jarmo Virtamo; Christian C Abnet; Demetrius Albanes; Neal D Freedman
Journal:  J Natl Cancer Inst       Date:  2011-06-21       Impact factor: 13.506

Review 4.  Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma.

Authors:  Sung Soo Kim; Victoria E Ruiz; Jaqueline D Carroll; Steven F Moss
Journal:  Cancer Lett       Date:  2010-08-07       Impact factor: 8.679

5.  Assay of gastrin and somatostatin in gastric antrum tissues of children with chronic gastritis and duodenal ulcer.

Authors:  Xiao-Zhi Xie; Zhi-Guang Zhao; Dan-Si Qi; Zong-Min Wang
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

6.  Gastric acid normosecretion is not essential in the pathogenesis of mild erosive gastroesophageal reflux disease in relation to Helicobacter pylori status.

Authors:  Tomohiko Shimatani; Masaki Inoue; Nobue Harada; Yoko Horikawa; Masuo Nakamura; Susumu Tazuma
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

Review 7.  Acid suppression and gastric atrophy: sifting fact from fiction.

Authors:  R M Genta
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

Review 8.  Pathobiology of Helicobacter pylori infection.

Authors:  D R Cave; P J Goddard
Journal:  Yale J Biol Med       Date:  1998 Mar-Apr

9.  Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations.

Authors:  Reuben Veysey-Smith; Andrew R Moore; Senthil V Murugesan; Laszlo Tiszlavicz; Graham J Dockray; Andrea Varro; D Mark Pritchard
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-18       Impact factor: 5.555

10.  Serum ghrelin and esophageal and gastric cancer in two cohorts in China.

Authors:  Natalie R Pritchett; Marlena Maziarz; Xiao-Ou Shu; Farin Kamangar; Sanford M Dawsey; Jin-Hu Fan; Bu-Tian Ji; Yu-Tang Gao; Yong-Bing Xiang; You-Lin Qiao; Honglan Li; Gong Yang; Shao-Ming Wang; Frank Z Stanczyk; Wong-Ho Chow; Hormuzd A Katki; Wei Zheng; Qing Lan; Neal D Freedman; Nat Rothman; Christian C Abnet; Gwen Murphy
Journal:  Int J Cancer       Date:  2019-08-12       Impact factor: 7.316

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.